Codiak BioSciences (CDAK) Prices 2.75M Share Common Offering at $21/Sh

Codiak BioSciences, Inc. (NASDAQ: CDAK) announced today the pricing of its underwritten public offering of 2,750,000 shares of its common stock at a public offering price of $21.00 per share, for gross proceeds of approximately $57.8 million, before deducting underwriting discounts and commissions and offering expenses. All of the shares are being offered by Codiak. In addition, Codiak has granted the underwriters a 30-day option to purchase up to an additional 412,500 shares of its common stock, at the public offering price, less underwriting discounts and commissions. All the shares to be sold in the proposed offering will be sold by Codiak.

The offering is expected to close on February 17, 2021, subject to customary closing conditions.

Goldman Sachs & Co. LLC, Evercore ISI and William Blair are acting as joint book-running managers for the offering and as representatives of the underwriters. Wedbush PacGrow is acting as lead manager for the offering.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission (“SEC”) and became effective on February 11, 2021.

You May Also Be Interested In

• VICI Properties closes $1.75B senior unsecured notes offering
• bioAffinity Technologies closes $4M private placement via pre-funded warrants
• Standard Nuclear names former DOE nuclear policy chief to its board